ROR1 and cancer: The activation of the PI3K-AKT-GSK3β pathway downstream of ROR1 is known to promote EMT by increased expression of mesenchymal markers Snail, Twist1, and MMP9, which all play a significant role in the migration and invasion of cancer (Figure 2A) [37–40].